Skip to main content
Caplight Logo









Oova

Oova

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.oova.life/

Last Round

Series A

Jun 12, 2023

Total Funding Raised

$11.66M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Oova is a health technology company that provides an at-home testing platform that uses urine tests and an AI-powered mobile application to quantitatively measure and monitor luteinizing hormone, estrogen, and progesterone.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, D2C Brands, Healthcare Analytics, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

fertility trackingat-home hormone testingfemtechremote patient monitoringRPMcomputer visionfertility monitorhormone trackingdigital healthovulation trackerlateral flow assayHIPAA-compliant softwareD2C healthclinical fertilitysubscription health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oova Comparables

Compare Oova with similar companies based on industry and business-model similarity.

Oova comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mira
92%
Proov
88%
Eli Health
86%

Oova Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 12, 2023
SeedJul 27, 2021
GrantApr 30, 2021
Pre SeedFeb 26, 2019

Key People

Founding team and executive leadership

Ioana Calcev

Chief Operating Officer

Executive Team

Oova Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 53% MoM, from 50.5K to 77.4K.

  • Jan 1, 2026

    Massachusetts General Hospital, Jefferson Health, and US Fertility now use the platform.

Recent news

Latest coverage and updates

  • partners_withJul 20, 2026

    OOVA, Inc. partnered with Mamaya Health on Jul 20th '26.

  • integrates_withJul 7, 2026

    OOVA, Inc. integrates with Ouraring.

Oova Filings

Explore SEC and related filing metadata, where available.

Oova filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oova's valuation, stock price, and market status.

Is Oova a public or private company?

Oova is a private company.

What is the current stock price of Oova?

Oova is a private company with no public stock price. No recent secondary market data is available.

How much is Oova worth (valuation)?

Valuation information for Oova is not publicly available.

Can I buy Oova stock?

Oova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oova's last funding round?

Oova's most recent funding round was Series A on June 12, 2023.

Who are the main investors in Oova?

Key investors in Oova include Spero Ventures.

Will Oova IPO soon?

No public IPO plans have been announced for Oova.

How can I track Oova secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oova's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range17
Year Founded2017
Last FundingJun 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?